Monday, November 16, 2009

NeurogesX wins FDA approval of pain patch - Bizjournals.com


NeurogesX wins FDA approval of pain patch
Bizjournals.com
NeurogesX stock, which closed the normal trading day down 4 cents to $8.24 per share, rose 86 cents in after-hours trading. The Qutenza patch provides up to ...

and more »
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)